| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/26/2008 | EP1562934B1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 03/26/2008 | EP1527075B1 Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands |
| 03/26/2008 | EP1509218A4 Peptide deformylase inhibitors |
| 03/26/2008 | EP1467997B1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 03/26/2008 | CN101151265A Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| 03/26/2008 | CN100377004C Image forming material and ammonium compound |
| 03/26/2008 | CN100376578C Indole group alkaloid of sector Gouyahua, and application for preparing drug-breaking medicine |
| 03/26/2008 | CN100376577C Method for preparing vindoline and Catharanthine |
| 03/26/2008 | CN100376576C Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 03/26/2008 | CN100376575C [1,4]diazepino[6,7,1-ij]quinoline derivatives as anti psychotic and antiobesity agents |
| 03/26/2008 | CN100376574C Preparation process of taytrolazole |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376572C Anti-infective agents |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348432 6-(3-nitro-phenyl)-3,3-spiro[cyclohexane]-imidazo[1,2-a]pyridin-2-one; depletion of estrogen, osteopenia, osteoporosis; hormone sensitive cancers, hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348338 PPAR active compounds |
| 03/25/2008 | US7348337 heterocyclic oxo amides such as 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione, used as viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348331 such as 6-(2,4-difluoro-phenoxy)-2-((S)-(+)-2-hydroxy-1-methyl-ethylamino)-8-((S)-2-hydroxy-propyl)-8H-pyrido[2,3-d]pyrimidin-7-one, used for treating p38 map kinase mediated disorders such as arthritis, Alzheimer's disease, gastrointestinal or respiratory system disorders |
| 03/25/2008 | US7348326 in brain; (2,5-difluorodifluorophenyl)-N-methyl-N-((1-propylbenzimidazol-2-yl)methyl)carboxamide; anxiolitic and antidepressant; finding and altering the signal-transducing activity of gamma aminobutyric acid (GABA) receptors; detectably-labeled antagonist/agonist of GABAR |
| 03/25/2008 | US7348325 Pyrrolotriazine kinase inhibitors |
| 03/25/2008 | US7348324 Cyclic amine compounds as CCR5 antagonists |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/25/2008 | CA2173493C Fused pyridazine compounds |
| 03/20/2008 | WO2008033456A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabilism |
| 03/20/2008 | WO2008033447A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | WO2008033431A1 Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032162A1 Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors |
| 03/20/2008 | WO2008032157A2 Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 03/20/2008 | WO2008031788A1 Aminoazepine derivatives as highly efficient inhibitors of the inducible nitric oxide synthase |
| 03/20/2008 | WO2008031750A2 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine |
| 03/20/2008 | WO2008031749A1 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives comprising optical resolution of an enamine |
| 03/20/2008 | WO2008031556A2 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions |
| 03/20/2008 | WO2008031513A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | WO2008016700A3 N-oxide compounds for therapeutics uses |
| 03/20/2008 | WO2008016661A3 Morpholino compounds for treating inflammatory and demyelinating diseases and cancers |
| 03/20/2008 | WO2008005910A3 Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 03/20/2008 | WO2007146087A3 SUBSTITUTED PYRAZOLO [1,5-α] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE |
| 03/20/2008 | WO2007130468A3 Pyrido [2, 3-b] pyrazine and [1, 8] -naphthyridine derivatives as alk and c-met inhibitors |
| 03/20/2008 | WO2007084391A3 Thiazole compounds as protein kinase b ( pkb) inhibitors |
| 03/20/2008 | US20080070943 Sulfonyldihydroimidazopyridinone compounds as 5-hydroxytryptamine-6 ligands |
| 03/20/2008 | US20080070942 Antiulcer, weakly inhibit gastric acid secretion, reduce the risk of stomach cancer, bioavailability, good pharmacokinetic properties; 2-(pyridylmethylsulfinyl)benzimidazoles such as 2-([4-3-methoxy-propoxy)-3-methylpyridine-2-yl]-methyl-sulfinyl)-1H-5-difluoromethoxybenzimidazole sodium salt |
| 03/20/2008 | US20080070941 Derivatives of n-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics |
| 03/20/2008 | US20080070940 Side effect reduction of emesis; phosphodiesterase 4 (PDE4) inhibitor; 2-(3'-[3-[(cyclopropylamino)carbonyl)-4-oxo-1,8-naphthyridin-1(4H)-yl]-3-fluoro-1,1'-biphenyl-4-yl)cyclopropanecarboxylic acid, sodium salt; crystalline forms; allergies, autoimmune diseases, cancer, neurodegenerative disorders |
| 03/20/2008 | US20080070916 Treating disorders such as proliferative diseases, and cancer; compounds can act as probes of biological function; libraries; for example, 2-ethoxy-3-(2-hydroxyethoxyethoxyethyl)-4-(1-acetylindol-3-yl)-6-(morpholinocarbonyl)-2H-3,4-dihydropyran |
| 03/20/2008 | US20080070913 Thieno [ 3,2-b] pyridine-6-carbonitriles and thieno [2,3-b] pyridine-5-carbonitriles as protein kinase inhibitors |
| 03/20/2008 | US20080070912 Phosphodiesterase inhibitors; neuropathic pain, inflammation, opioid dependence or withdrawal; 2-amino-1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one for example |
| 03/20/2008 | US20080070906 Quinolinone derivatives |
| 03/20/2008 | US20080070888 Spirocyclic azetidin(one); 2-(3-chloro-4-fluorophenyl)-7-[5-fluoro-6-(trifluoromethyl)-1H-benzimidazol-2-yl]-3-(2-pyridinyl)-2,7-diazaspiro[3.5]nonan-1-one; T-type calcium channel blockers |
| 03/20/2008 | US20080070881 Prostate Cancer Treatment |
| 03/20/2008 | CA2663947A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | CA2663502A1 Azetidinone derivatives and methods of use thereof |
| 03/20/2008 | CA2663500A1 Spiro-condensed azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
| 03/20/2008 | CA2663434A1 Spirocyclic azetidinone derivatives for the treatment of disorders of lipid metabolism, pain, diabetes and other disorders |
| 03/20/2008 | CA2663297A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders |
| 03/20/2008 | CA2663189A1 Benzimidazolone derivatives |
| 03/20/2008 | CA2663113A1 Nicotinic acid derivatives as modulators of metabotropic glutanate receptors |
| 03/20/2008 | CA2662768A1 Synthesis of 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 03/20/2008 | CA2662419A1 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine |
| 03/20/2008 | CA2662413A1 Process for the preparation of pyrido[2,1-a]isoquinoline derivatives comprising optical resolution of an enamine |
| 03/19/2008 | EP1900738A2 Substituted pyrroline kinase inhibitors |
| 03/19/2008 | EP1899341A1 Spiro-imidaznaphthyridine derivatives as gastric acid secretion inhibitors |
| 03/19/2008 | EP1899340A2 Non-nucleoside reverse transcriptase inhibitors |
| 03/19/2008 | EP1899339A1 1,2-dihydro-spiro(3h-indole-3-4 -piperidine) compounds as modulators of the mas receptor novel |
| 03/19/2008 | EP1899338A1 Spiro-benzimidazoles as inhibitors of gastric acid secretion |
| 03/19/2008 | EP1899337A1 Process for the preparation of 3,7-diazabicyclo[3.3.1]nonane compounds |
| 03/19/2008 | EP1899336A1 Cysteine protease inhibitors |
| 03/19/2008 | EP1899335A1 Pyrroloquinoline derivatives and their use as protein kinase inhibitors |
| 03/19/2008 | EP1899334A2 Naphthyridine compounds |
| 03/19/2008 | EP1899333A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 03/19/2008 | EP1899332A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c. |
| 03/19/2008 | EP1899330A1 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 03/19/2008 | EP1899318A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 03/19/2008 | EP1713804B1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 03/19/2008 | EP1638966B1 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO ¬3,4-d PYRIMIDINE AND USES THEREOF |
| 03/19/2008 | EP1562933B1 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 03/19/2008 | EP1499316B1 (1-4-piperidinyl)benzimidazole derivatives useful as histamine h3 antagonists |
| 03/19/2008 | EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects |
| 03/19/2008 | EP1363630B1 Kappa opioid receptor ligands |
| 03/19/2008 | EP1283711B1 Peptide deformylase inhibitors |
| 03/19/2008 | CN101146889A Luminous compound containing lanthanide ion |
| 03/19/2008 | CN101146810A Method for making 1-substituted 1H-imidazo[4,5-c]quinolin-4-amine compounds and intermediates therefor |
| 03/19/2008 | CN101146809A Process for preparing quinoline compounds and products obtained therefrom |
| 03/19/2008 | CN101146808A Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors |
| 03/19/2008 | CN101146807A Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-C][1,5]naphthyridin-4-amine |
| 03/19/2008 | CN101146776A PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/19/2008 | CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 03/19/2008 | CN101146540A Hiv整合酶抑制剂 Hiv integrase inhibitors |
| 03/19/2008 | CN101146534A Substituted pyrazolopyridines, compositions containing them, method for the production thereof, and their use |
| 03/19/2008 | CN101143830A Organic electroluminescent material and application thereof |
| 03/19/2008 | CN100375742C 4-oxoquinoline compounds and its use |
| 03/18/2008 | US7345175 Biphenyl derivatives |
| 03/18/2008 | US7345171 Isethionate salt of a selective CKD4 inhibitor |